Ganoderma lucidum suppresses endothelial cell cytotoxicity and proteinuria in persistent proteinuric focal segmental glomerulosclerosis (FSGS) nephrosis
A persistent proteinuria is commonly observed in nephrotic patient with focal segmental glomerulosclerosis (FSGS) under treatment with prednisolone ± cyclophosphamide or with vasodilators (ACEI + AII receptor antagonist, calcium channel blocker and antiplatelet agent). Fourteen such patients with pe...
Saved in:
Published in | Clinical hemorheology and microcirculation Vol. 31; no. 4; pp. 267 - 272 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
London, England
SAGE Publications
01.01.2004
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | A persistent proteinuria is commonly observed in nephrotic patient with focal
segmental glomerulosclerosis (FSGS) under treatment with prednisolone ±
cyclophosphamide or with vasodilators (ACEI + AII receptor antagonist, calcium
channel blocker and antiplatelet agent). Fourteen such patients with persistent
proteinuria were subject to be treated with Ganoderma lucidum. Initial study
revealed an enhanced endothelial cell cytotoxicity induced by patient's serum,
and an altered immunocirculatory balance with predominant proinflammatory
cytokine TNF alpha activity in the presence of defective anti‐inflammatory
cytokine interleukin‐10. Treatment with Ganoderma lucidum suppressed endothelial
cell cytotoxicity, restored immunocirculatory balance and successfully
suppressed proteinuria in all of these 14 patients. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 |
ISSN: | 1386-0291 1875-8622 |
DOI: | 10.3233/CHM-2004-ch725 |